Evidence map›Paper›PMID 32029601›Full record

ReviewScience (New York, N.Y.)2020

The biology

Raghu Kalluri, Valerie S LeBleu

6 registry-linked trialsAbstract readReview
In one paragraph

Review in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 6,237 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6,237citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05476029 unknown statusnot on this mapstarted 2022, after this paper: background citation

Study on Exosomes and Biomarkers in Plasma and Alveolar Lavage Fluid of Patients With Sepsis Complicated With ARDS

Typeobservational_patient_registrySponsorTianjin Nankai HospitalRan2022 to 2023Enrolled20ConditionsSepsis Complicated With ARDSArmsBlood samples and alveolar lavage fluid were collected
NCT06070974 unknown statusnot on this mapstarted 2023, after this paper: background citation

ExosoMe as Integrative Tool for pRognostic Stratification of Adverse Cardiac remodeLing in stEmi Patients: the MIRACLE Study

TypeobservationalSponsorCentro Cardiologico MonzinoRan2023 to 2026Enrolled100ConditionsSTEMIArmsCMR and blood collection
NCT06490055 completednot on this map

Predicting the Efficacy of Paclitaxel Plus Ramucirumab in Advanced Gastric Cancer.

Typeobservational_patient_registrySponsorCity of Hope Medical CenterRan2018 to 2025Enrolled162ConditionsGastric Cancer, Chemotherapy Effect, Paclitaxel, RamucirumabArmsPaclitaxel
NCT06798558 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Phase II Study of Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

TypeinterventionalSponsorHackensack Meridian HealthRan2025 to 2029Enrolled54ConditionsProstate AdenocarcinomaArmsLu-17-PSMA-617
NCT07144241 phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients

TypeinterventionalSponsorIndonesia UniversityRan2025 to 2026Enrolled50ConditionsType 2 Diabetes MellitusArmsMesenchymal Stromal/Stem Cells-Derived Exosomes (Exo-HWS + 1 vial Exo-HUVEC) Therapy, Mesenchymal Stromal/Stem Cells-Derived Exosomes (Exo-HWS ) Therapy
NCT07635459 early_phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Single-Centre, Randomised, Double-Blind, Placebo-Controlled Exploratory Clinical Study of a Thermosensitive Gel Nasal Spray Containing Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes, Azelastine and Recombinant Human Interferon α-2b for the Treatment of Chronic Rhinosinusitis (Acute Phase)

TypeinterventionalSponsorThe First Affiliated Hospital of Xinxiang Medical CollegeRan2026 to 2027Enrolled108ConditionsChronic Rhinosinusitis Without PolypsArmsExosomes, Azelastine, and Interferon alpha-2b, Azelastine and Interferon alpha-2b, Placebo Gel Matrix
3 · Its place in the literature

Who cites it

6,237 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell lines.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

6,177 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Raghu KalluriDepartment of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA. rkalluri@mdanderson.org.ORCID 0000-0002-2190-547X
Valerie S LeBleuDepartment of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-8514-8551

Funding

Rigorous and reproducible mutational analysis of the urinary exosomal DNAR01CA231465 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DINNEY, COLIN P.N., KALLURI, RAGHU · 2019 to 2023
$3.1M
Exosomes in Cancer TherapyR01CA213233 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KALLURI, RAGHU · 2017 to 2021
$2.0M
Employing mouse models to translate early detection of pancreas cancerR01CA195733 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KALLURI, RAGHU, PIWNICA-WORMS, DAVID · 2015 to 2017
$1.6M
NCI NIH HHS R01 CA195733NCI NIH HHS R01 CA213233NCI NIH HHS R01 CA231465
6 · The paper itself

Abstract

The study of extracellular vesicles (EVs) has the potential to identify unknown cellular and molecular mechanisms in intercellular communication and in organ homeostasis and disease. Exosomes, with an average diameter of ~100 nanometers, are a subset of EVs. The biogenesis of exosomes involves their origin in endosomes, and subsequent interactions with other intracellular vesicles and organelles generate the final content of the exosomes. Their diverse constituents include nucleic acids, proteins, lipids, amino acids, and metabolites, which can reflect their cell of origin. In various diseases, exosomes offer a window into altered cellular or tissue states, and their detection in biological fluids potentially offers a multicomponent diagnostic readout. The efficient exchange of cellular components through exosomes can inform their applied use in designing exosome-based therapeutics.

Indexed as

ExosomesAnimalsCardiovascular DiseasesCell CommunicationHumansInfectionsMetabolic DiseasesNeoplasmsNeurodegenerative DiseasesReproduction

Identifiers

PMID32029601
PMCPMC7717626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.